...
首页> 外文期刊>Osteoarthritis and cartilage >Compositional MRI techniques for evaluation of cartilage degeneration in osteoarthritis
【24h】

Compositional MRI techniques for evaluation of cartilage degeneration in osteoarthritis

机译:组合MRI技术评估骨关节炎软骨退变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Osteoarthritis (OA), a leading cause of disability, affects 27 million people in the United States and its prevalence is rising along with the rise in obesity. So far, biomechanical or behavioral interventions as well as attempts to develop disease-modifying OA drugs have been unsuccessful. This may be partly due to antiquated imaging outcome measures such as radiography, which are still endorsed by regulatory agencies such as the United States Food and Drug Administration (FDA) for use in clinical trials. Morphological magnetic resonance imaging (MRI) allows unparalleled multi-feature assessment of the OA joint. Furthermore, advanced MRI techniques also enable evaluation of the biochemical or ultrastructural composition of articular cartilage relevant to OA research. These compositional MRI techniques have the potential to supplement clinical MRI sequences in identifying cartilage degeneration at an earlier stage than is possible today using morphologic sequences only. The purpose of this narrative review is to describe compositional MRI techniques for cartilage evaluation, which include T2 mapping, T2* Mapping, T1 rho, dGEMRIC, gagCEST, sodium imaging and diffusion weighted imaging (DWI). We also reviewed relevant clinical studies that have utilized these techniques for the study of OA. The different techniques are complementary. Some focus on isotropy or the collagen network (e.g., T2 mapping) and others are more specific in regard to tissue composition, e.g., gagCEST or dGEMRIC that convey information on the GAG concentration. The application and feasibility of these techniques is also discussed, as they will play an important role in implementation in larger clinical trials and eventually clinical practice. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
机译:骨关节炎(OA)是致残的主要原因,在美国影响了2700万人,其患病率随着肥胖症的增加而上升。迄今为止,生物力学或行为干预以及开发可缓解疾病的OA药物的尝试均未成功。这可能部分是由于过时的成像结果测量方法(例如射线照相),仍得到美国食品和药物管理局(FDA)等监管机构的认可,可用于临床试验。形态磁共振成像(MRI)可以对OA关节进行无与伦比的多特征评估。此外,先进的MRI技术还可以评估与OA研究相关的关节软骨的生化或超微结构。与目前仅使用形态序列相比,这些成分MRI技术具有在更早阶段识别软骨退变方面补充临床MRI序列的潜力。本篇综述的目的是描述用于软骨评估的成分MRI技术,包括T2映射,T2 *映射,T1 rho,dGEMRIC,gagCEST,钠成像和弥散加权成像(DWI)。我们还回顾了利用这些技术进行OA研究的相关临床研究。不同的技术是互补的。一些关注于各向同性或胶原网络(例如,T2作图),而另一些关注于组织组成,例如,传达关于GAG浓度的信息的gagCEST或dGEMRIC。还讨论了这些技术的应用和可行性,因为它们将在大型临床试验和最终的临床实践中发挥重要作用。 (C)2015年国际骨关节炎研究学会。由Elsevier Ltd.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号